January 27th 2024
Saby George, MD, FACP, discusses the efficacy and safety of subcutaneous nivolumab in patients with clear cell renal cell carcinoma, according to findings from the phase 3 CheckMate 67T study.
January 26th 2024
Dalia Kaakour, MD, discusses real-world findings on genomic testing patterns in patients with prostate cancer.